Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

KGEI vs BHST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KGEI Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

KGEI Overall Winner 6-Pillar Tally: KGEI 4 – 1 BHST (1 Tie) Matrix Metrics: KGEI 9 – 1 BHST

As of Nov 20, 2026, Kolibri Global Energy Inc. (KGEI) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KGEI carries a Unified Composite Score of 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. KGEI 49.0/100 HOLD), KGEI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.8% vs. -18.0% operating margin) and revenue trajectory (+20.9% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: KGEI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KGEI vs BHST
KGEI NASDAQ Head-to-Head Winner
Kolibri Global Energy Inc. Common Stock
Crude Petroleum & Natural Gas
$4.47
-3.14% 1D
Market Cap $166.1M
TTM Revenue $75M
Forward P/E 5.3x
Beta / 30D Vol -0.73β · 64% Vol
Unified Composite Score
49.0 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 25
RSI-14: 24.6 · SMA20: $5.78 · SMA50: $6.26
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58

6-Pillar Scorecard Institutional Category Breakdown (KGEI 4 – 1 BHST)

Columns: Metric · KGEI · BHST
1. Valuation Multiples KGEI
Forward P/E 5.3x N/M
Trailing P/E 8.6x N/M
PEG Ratio 0.58x N/M
EV / Revenue 2.2x 0.7x
2. Growth & Scale KGEI
Revenue Growth (YoY) +20.9% +3.8%
Earnings Growth (YoY) -0.6% +0.0%
TTM Revenue (USD) $75M $35M
Market Cap $166.1M $29.9M
3. Profitability & Quality KGEI
Gross Margin 84.5% 59.0%
Operating Margin 39.8% -18.0%
Net Profit Margin 25.7% -31.2%
Return on Equity (ROE) 9.1% -142.5%
4. Balance Sheet & Cash Flow KGEI
Cash Generation (TTM) $47M EBITDA -$9.4M
Cash Flow Margin 62.4% EBITDA Mgn -26.6%
Net Cash / Leverage $6.19 Book/Sh · 9.1% ROE $5.1M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 44.7% of Rev ($34M) 77.0% of Rev ($27M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas E&P Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KGEI (9) vs BHST (1)
Institutional Metric KGEI BHST Criterion Row Edge
Market Capitalization
Scale
$166.1M $29.9M Larger Scale KGEI
Trailing P/E Ratio
Valuation
8.6x N/M Lower Multiple KGEI
Forward P/E Ratio
Valuation
5.3x N/M Lower Multiple KGEI
Revenue Growth (YoY)
Growth
+20.9% +3.8% Higher Growth KGEI
Operating Margin (TTM)
Profitability
39.8% -18.0% Higher Margin KGEI
Net Profit Margin
Profitability
25.7% -31.2% Higher Margin KGEI
Return on Equity (ROE)
Capital Efficiency
9.1% -142.5% Higher ROE KGEI
52-Week Range Position
Momentum
28% ($3–$7) 6% ($1–$7) Stronger Trend KGEI
Beta / 30D Volatility
Risk Regime
-0.73β · 64% Vol 0.25β · 86% Vol Lower Realized Risk KGEI
Unified Institutional Score
Composite Signal
49.0 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$75M $35M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
84.5% 59.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.58x PEG · 2.2x EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$47M EBITDA ($6.19 Book/Sh · 9.1% ROE) -$9.4M ($5.1M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +12.62 pp
KGEI: -35.24% · BHST: -22.62%
3M Horizon KGEI +11.42 pp
KGEI: -25.17% · BHST: -36.59%
6M Horizon KGEI +42.56 pp
KGEI: -23.76% · BHST: -66.32%
1Y Horizon KGEI +91.0 pp
KGEI: +11.6% · BHST: -79.4%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KGEI vs BHST. Trailing 12-month operating profitability (KGEI 39.8% vs BHST -18.0%) and valuation multiples (KGEI 5.3x vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KGEI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$75M
Gross Margin84.5%
Op. Margin39.8%
ROE / Fwd P/E9.1% · 5.3x
BHST ADR TTM Benchmark FX-Normalized USD
TTM Revenue$35M
Gross Margin59.0%
Op. Margin-18.0%
ROE / Fwd P/E-142.5% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KGEI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KGEI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KGEI Moat Profile High-Margin Pricing Power Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $166.1M market capitalization and 39.8% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($34M)
90D Engineering Disclosures 0 Published
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published

Investor FAQ KGEI vs BHST Key Questions & Quantitative Answers

As of Nov 20, 2026, Kolibri Global Energy Inc. (KGEI) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KGEI carries a Unified Composite Score of 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. KGEI 49.0/100 HOLD), KGEI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.8% vs. -18.0% operating margin) and revenue trajectory (+20.9% vs. +3.8% YoY). Technical & Structure Timing Caution: KGEI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KGEI leads the Growth & Scale pillar: KGEI posts +20.9% YoY revenue growth and -0.6% YoY earnings growth on $75M TTM revenue (84.5% gross margin, 39.8% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). On trailing 12-month operating scale, KGEI generates $75M in USD-normalized revenue versus $35M for BHST. In operating R&D and SG&A reinvestment, KGEI deploys 44.7% of Rev ($34M) (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.

KGEI screens cheaper on headline valuation multiples. KGEI trades at 5.3x Forward P/E, 8.6x Trailing P/E, 0.58x PEG, and 2.2x EV/Revenue (62.4% EBITDA margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KGEI (9.1% ROE) versus BHST (-142.5% ROE) capital efficiency.

In options market volatility and institutional positioning, KGEI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.73β · 64% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.